Elucidating the precise pharmacological mechanism of action (MOA) of naturally transpiring compounds could be challenging. While Tarselli et al. (sixty) produced the main de novo artificial pathway to conolidine and showcased that this naturally transpiring compound successfully suppresses responses to each chemically induced and inflammation-deriv